![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EAPP |
Gene summary for EAPP |
![]() |
Gene information | Species | Human | Gene symbol | EAPP | Gene ID | 55837 |
Gene name | E2F associated phosphoprotein | |
Gene Alias | BM036 | |
Cytomap | 14q13.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q56P03 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55837 | EAPP | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.45e-02 | 3.06e-01 | -0.0811 |
55837 | EAPP | HTA11_78_2000001011 | Human | Colorectum | AD | 1.15e-04 | 3.57e-01 | -0.1088 |
55837 | EAPP | HTA11_347_2000001011 | Human | Colorectum | AD | 1.08e-31 | 8.14e-01 | -0.1954 |
55837 | EAPP | HTA11_83_2000001011 | Human | Colorectum | SER | 1.15e-02 | 4.05e-01 | -0.1526 |
55837 | EAPP | HTA11_866_2000001011 | Human | Colorectum | AD | 3.33e-02 | 3.30e-01 | -0.1001 |
55837 | EAPP | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.49e-06 | 3.69e-01 | -0.059 |
55837 | EAPP | HTA11_10623_2000001011 | Human | Colorectum | AD | 1.10e-02 | 3.92e-01 | -0.0177 |
55837 | EAPP | HTA11_99999965104_69814 | Human | Colorectum | MSS | 7.59e-04 | 3.18e-01 | 0.281 |
55837 | EAPP | A015-C-203 | Human | Colorectum | FAP | 1.32e-09 | -2.20e-01 | -0.1294 |
55837 | EAPP | A002-C-201 | Human | Colorectum | FAP | 1.42e-03 | -2.05e-01 | 0.0324 |
55837 | EAPP | A001-C-108 | Human | Colorectum | FAP | 4.11e-04 | -1.19e-01 | -0.0272 |
55837 | EAPP | A002-C-205 | Human | Colorectum | FAP | 1.92e-07 | -1.14e-01 | -0.1236 |
55837 | EAPP | A015-C-006 | Human | Colorectum | FAP | 1.54e-04 | -2.93e-01 | -0.0994 |
55837 | EAPP | A015-C-106 | Human | Colorectum | FAP | 1.04e-02 | -1.34e-01 | -0.0511 |
55837 | EAPP | A002-C-114 | Human | Colorectum | FAP | 4.16e-05 | -1.99e-01 | -0.1561 |
55837 | EAPP | A015-C-104 | Human | Colorectum | FAP | 1.66e-09 | -2.05e-01 | -0.1899 |
55837 | EAPP | A001-C-014 | Human | Colorectum | FAP | 8.02e-04 | -1.83e-01 | 0.0135 |
55837 | EAPP | A002-C-016 | Human | Colorectum | FAP | 7.70e-06 | -2.04e-01 | 0.0521 |
55837 | EAPP | A015-C-002 | Human | Colorectum | FAP | 5.05e-04 | -3.13e-01 | -0.0763 |
55837 | EAPP | A002-C-116 | Human | Colorectum | FAP | 1.21e-12 | -2.06e-01 | -0.0452 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000636815 | Skin | cSCC | transcription elongation from RNA polymerase II promoter | 39/4864 | 69/18723 | 7.15e-08 | 1.78e-06 | 39 |
GO:003278413 | Skin | cSCC | regulation of DNA-templated transcription, elongation | 28/4864 | 53/18723 | 2.75e-05 | 3.09e-04 | 28 |
GO:003424313 | Skin | cSCC | regulation of transcription elongation from RNA polymerase II promoter | 19/4864 | 32/18723 | 6.64e-05 | 6.45e-04 | 19 |
GO:003296813 | Skin | cSCC | positive regulation of transcription elongation from RNA polymerase II promoter | 10/4864 | 13/18723 | 1.78e-04 | 1.50e-03 | 10 |
GO:003278614 | Skin | cSCC | positive regulation of DNA-templated transcription, elongation | 16/4864 | 27/18723 | 2.60e-04 | 2.10e-03 | 16 |
GO:00327854 | Skin | cSCC | negative regulation of DNA-templated transcription, elongation | 11/4864 | 18/18723 | 1.74e-03 | 1.06e-02 | 11 |
GO:00342444 | Skin | cSCC | negative regulation of transcription elongation from RNA polymerase II promoter | 10/4864 | 16/18723 | 2.25e-03 | 1.32e-02 | 10 |
GO:000635416 | Thyroid | PTC | DNA-templated transcription, elongation | 62/5968 | 91/18723 | 1.30e-12 | 5.91e-11 | 62 |
GO:000636816 | Thyroid | PTC | transcription elongation from RNA polymerase II promoter | 48/5968 | 69/18723 | 1.43e-10 | 4.81e-09 | 48 |
GO:00327846 | Thyroid | PTC | regulation of DNA-templated transcription, elongation | 38/5968 | 53/18723 | 3.07e-09 | 8.43e-08 | 38 |
GO:00342437 | Thyroid | PTC | regulation of transcription elongation from RNA polymerase II promoter | 24/5968 | 32/18723 | 6.76e-07 | 1.07e-05 | 24 |
GO:00327868 | Thyroid | PTC | positive regulation of DNA-templated transcription, elongation | 21/5968 | 27/18723 | 1.24e-06 | 1.79e-05 | 21 |
GO:00342445 | Thyroid | PTC | negative regulation of transcription elongation from RNA polymerase II promoter | 13/5968 | 16/18723 | 6.82e-05 | 5.97e-04 | 13 |
GO:00327855 | Thyroid | PTC | negative regulation of DNA-templated transcription, elongation | 14/5968 | 18/18723 | 8.31e-05 | 7.01e-04 | 14 |
GO:00329687 | Thyroid | PTC | positive regulation of transcription elongation from RNA polymerase II promoter | 11/5968 | 13/18723 | 1.34e-04 | 1.05e-03 | 11 |
GO:000635421 | Thyroid | ATC | DNA-templated transcription, elongation | 63/6293 | 91/18723 | 3.89e-12 | 1.55e-10 | 63 |
GO:000636822 | Thyroid | ATC | transcription elongation from RNA polymerase II promoter | 49/6293 | 69/18723 | 2.32e-10 | 6.72e-09 | 49 |
GO:003278414 | Thyroid | ATC | regulation of DNA-templated transcription, elongation | 39/6293 | 53/18723 | 3.04e-09 | 7.10e-08 | 39 |
GO:003424314 | Thyroid | ATC | regulation of transcription elongation from RNA polymerase II promoter | 25/6293 | 32/18723 | 3.13e-07 | 4.68e-06 | 25 |
GO:003278615 | Thyroid | ATC | positive regulation of DNA-templated transcription, elongation | 21/6293 | 27/18723 | 3.28e-06 | 3.69e-05 | 21 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EAPP | SNV | Missense_Mutation | c.445G>A | p.Ala149Thr | p.A149T | Q56P03 | protein_coding | tolerated(0.21) | possibly_damaging(0.597) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
EAPP | SNV | Missense_Mutation | c.646G>A | p.Glu216Lys | p.E216K | Q56P03 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-GM-A2D9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
EAPP | insertion | Frame_Shift_Ins | novel | c.374_375insA | p.Lys126GlufsTer10 | p.K126Efs*10 | Q56P03 | protein_coding | TCGA-UL-AAZ6-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | herceptin | SD | ||
EAPP | SNV | Missense_Mutation | novel | c.310N>T | p.Asp104Tyr | p.D104Y | Q56P03 | protein_coding | deleterious(0) | possibly_damaging(0.653) | TCGA-MA-AA41-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
EAPP | SNV | Missense_Mutation | rs149923274 | c.836N>G | p.Asn279Ser | p.N279S | Q56P03 | protein_coding | deleterious(0.04) | benign(0.076) | TCGA-AA-A03F-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
EAPP | SNV | Missense_Mutation | c.347N>T | p.Arg116Ile | p.R116I | Q56P03 | protein_coding | tolerated(0.05) | benign(0) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
EAPP | SNV | Missense_Mutation | c.800N>T | p.Ala267Val | p.A267V | Q56P03 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EAPP | SNV | Missense_Mutation | c.437N>A | p.Arg146Lys | p.R146K | Q56P03 | protein_coding | tolerated(0.19) | benign(0.026) | TCGA-AG-4007-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
EAPP | SNV | Missense_Mutation | c.710C>A | p.Ser237Tyr | p.S237Y | Q56P03 | protein_coding | tolerated(0.12) | benign(0.34) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
EAPP | deletion | Frame_Shift_Del | novel | c.833delN | p.Phe278SerfsTer4 | p.F278Sfs*4 | Q56P03 | protein_coding | TCGA-AA-3966-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |